Skip to main content
SpringerLink
Log in

Metabolic Lung Diseases

  • Chapter
  • First Online:
Pathology of Lung Disease

  • 3027 Accesses

Abstract

Metabolic lung disease can be classified as protein deposition (amyloidosis), disturbances of calcium metabolism, disturbed metabolism of lipids and lipoproteins; some of these diseases are systemic, others affect only the lung. Most of them are rare diseases, except amyloidosis, which often affect the lung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Glabe CG, Kayed R. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology. 2006;66:S74–8.

    Article  CAS  PubMed  Google Scholar 

  2. Stefani M, Dobson CM. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med. 2003;81:678–99.

    Article  CAS  PubMed  Google Scholar 

  3. Westermark P. Aspects on human amyloid forms and their fibril polypeptides. FEBS J. 2005;272:5942–9.

    Article  CAS  PubMed  Google Scholar 

  4. Kobayashi H, Matsuoka R, Kitamura S, Tsunoda N, Saito K. Sjogren’s syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest. 1988;94:438–40.

    Article  CAS  PubMed  Google Scholar 

  5. Marenco JL, Sanchez-Burson J, Ruiz Campos J, Jimenez MD, Garcia-Bragado F. Pulmonary amyloidosis and unusual lung involvement in SLE. Clin Rheumatol. 1994;13:525–7.

    Article  CAS  PubMed  Google Scholar 

  6. Sharma OP. Unusual systemic disorders associated with interstitial lung disease. Curr Opin Pulm Med. 2001;7:291–4.

    Article  CAS  PubMed  Google Scholar 

  7. Lachmann HJ, Hawkins PN. Systemic amyloidosis. Curr Opin Pharmacol. 2006;6:214–20.

    Article  CAS  PubMed  Google Scholar 

  8. Linke RP, Oos R, Wiegel NM, Nathrath WB. Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it. Acta Histochem. 2006;108:197–208.

    Article  PubMed  Google Scholar 

  9. Kebbel A, Rocken C. Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol. 2006;30:673–83.

    Article  PubMed  Google Scholar 

  10. Xiang R, Luo Y, Niethammer AG, Reisfeld RA. Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis. Immunol Rev. 2008;222:117–28.

    Article  CAS  PubMed  Google Scholar 

  11. Lara JF, Catroppo JF, Kim DU, da Costa D. Dendriform pulmonary ossification, a form of diffuse pulmonary ossification: report of a 26-year autopsy experience. Arch Pathol Lab Med. 2005;129:348–53.

    PubMed  Google Scholar 

  12. Yoon HK, Moon HS, Park SH, Song JS, Lim Y, Kohyama N. Dendriform pulmonary ossification in patient with rare earth pneumoconiosis. Thorax. 2005;60:701–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Rajwani NA, Puttagunta L, Barrie J, Kalluri M. Pulmonary ossification syndrome in a patient with chronic thromboembolic pulmonary hypertension. Can Respir J. 2014;21:83–5.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chan ED, Morales DV, Welsh CH, McDermott MT, Schwarz MI. Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med. 2002;165:1654–69.

    Article  PubMed  Google Scholar 

  15. Chung MJ, Lee KS, Franquet T, Muller NL, Han J, Kwon OJ. Metabolic lung disease: imaging and histopathologic findings. Eur J Radiol. 2005;54:233–45.

    Article  PubMed  Google Scholar 

  16. Madhusudhan KS, Shad PS, Sharma S, Goel A, Mahajan H. Metastatic pulmonary calcification in chronic renal failure. Int Urol Nephrol. 2012;44:1285–7.

    Google Scholar 

  17. Eggert CH, Albright RC. Metastatic pulmonary calcification in a dialysis patient: case report and a review. Hemodial Int. 2006;10 Suppl 2:S51–5.

    Article  PubMed  Google Scholar 

  18. Marchiori E, Muller NL, Souza Jr AS, Escuissato DL, Gasparetto EL, de Cerqueira EM. Unusual manifestations of metastatic pulmonary calcification: high-resolution CT and pathological findings. J Thorac Imaging. 2005;20:66–70.

    Article  PubMed  Google Scholar 

  19. Al-Alawi AS. Familial occurrence of pulmonary alveolar microlithiasis in 3 siblings. Saudi Med J. 2006;27:238–40.

    PubMed  Google Scholar 

  20. Corut A, Senyigit A, Ugur SA, Altin S, Ozcelik U, Calisir H, Yildirim Z, Gocmen A, Tolun A. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet. 2006;79:650–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Huqun, Izumi S, Miyazawa H, Ishii K, Uchiyama B, Ishida T, Tanaka S, Tazawa R, Fukuyama S, Tanaka T, Nagai Y, Yokote A, Takahashi H, Fukushima T, Kobayashi K, Chiba H, Nagata M, Sakamoto S, Nakata K, Takebayashi Y, Shimizu Y, Kaneko K, Shimizu M, Kanazawa M, Abe S, Inoue Y, Takenoshita S, Yoshimura K, Kudo K, Tachibana T, Nukiwa T, Hagiwara K. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med. 2007;175:263–8.

    Article  CAS  PubMed  Google Scholar 

  22. Mariotta S, Ricci A, Papale M, De Clementi F, Sposato B, Guidi L, Mannino F. Pulmonary alveolar microlithiasis: report on 576 cases published in the literature. Sarcoidosis Vasc Diff Lung Dis. 2004;21:173–81.

    Google Scholar 

  23. Prakash UB. Pulmonary alveolar microlithiasis. Semin Respir Crit Care Med. 2002;23:103–13.

    Article  PubMed  Google Scholar 

  24. Hamvas A, Nogee LM, White FV, Schuler P, Hackett BP, Huddleston CB, Mendeloff EN, Hsu FF, Wert SE, Gonzales LW, Beers MF, Ballard PL. Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene. Am J Respir Cell Mol Biol. 2004;30:771–6.

    Article  CAS  PubMed  Google Scholar 

  25. Whitsett JA, Wert SE, Trapnell BC. Genetic disorders influencing lung formation and function at birth. Hum Mol Genet. 2004;13(Spec No 2):R207–15.

    Article  CAS  PubMed  Google Scholar 

  26. Tredano M, Griese M, Brasch F, Schumacher S, de Blic J, Marque S, Houdayer C, Elion J, Couderc R, Bahuau M. Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease. Am J Med Genet. 2004;126A:18–26.

    Article  PubMed  Google Scholar 

  27. Bruder E, Hofmeister J, Aslanidis C, Hammer J, Bubendorf L, Schmitz G, Rufle A, Buhrer C. Ultrastructural and molecular analysis in fatal neonatal interstitial pneumonia caused by a novel ABCA3 mutation. Mod Pathol. 2007;20:1009–18.

    Article  CAS  PubMed  Google Scholar 

  28. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol. 2009;12:253–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Trapnell BC, Whitsett JA. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol. 2002;64:775–802.

    Article  CAS  PubMed  Google Scholar 

  30. Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol. 2002;27:481–6.

    Article  CAS  PubMed  Google Scholar 

  31. Latzin P, Tredano M, Wust Y, de Blic J, Nicolai T, Bewig B, Stanzel F, Kohler D, Bahuau M, Griese M. Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis. Thorax. 2005;60:39–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ioachimescu OC, Kavuru MS. Pulmonary alveolar proteinosis. Chron Respir Dis. 2006;3:149–59.

    Article  CAS  PubMed  Google Scholar 

  33. Thomassen MJ, Raychaudhuri B, Bonfield TL, Malur A, Abraham S, Barna BP, Kavuru MS. Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis. Autoimmunity. 2003;36:285–90.

    Article  CAS  PubMed  Google Scholar 

  34. Brasch F, Birzele J, Ochs M, Guttentag SH, Schoch OD, Boehler A, Beers MF, Muller KM, Hawgood S, Johnen G. Surfactant proteins in pulmonary alveolar proteinosis in adults. Eur Respir J. 2004;24:426–35.

    Article  CAS  PubMed  Google Scholar 

  35. Parto K, Svedstrom E, Majurin ML, Harkonen R, Simell O. Pulmonary manifestations in lysinuric protein intolerance. Chest. 1993;104:1176–82.

    Article  CAS  PubMed  Google Scholar 

  36. Douda DN, Farmakovski N, Dell S, Grasemann H, Palaniyar N. SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance. Orphanet J Rare Dis. 2009;4:29.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Barilli A, Rotoli BM, Visigalli R, Bussolati O, Gazzola GC, Kadija Z, Rodi G, Mariani F, Ruzza ML, Luisetti M, Dall’asta V. In lysinuric protein intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages. Orphanet J Rare Dis. 2010;5:32.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Edwards V, Cutz E, Viero S, Moore AM, Nogee L. Ultrastructure of lamellar bodies in congenital surfactant deficiency. Ultrastruct Pathol. 2005;29:503–9.

    Article  CAS  PubMed  Google Scholar 

  39. Guillemot N, Troadec C, de Villemeur TB, Clement A, Fauroux B. Lung disease in Niemann-Pick disease. Pediatr Pulmonol. 2007;42:1207–14.

    Article  PubMed  Google Scholar 

  40. Dinwiddie R, Sonnappa S. Systemic diseases and the lung. Paediatr Respir Rev. 2005;6:181–9.

    Article  PubMed  Google Scholar 

  41. Miller A, Brown LK, Pastores GM, Desnick RJ. Pulmonary involvement in type 1 Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease. Clin Genet. 2003;63:368–76.

    Article  CAS  PubMed  Google Scholar 

  42. Ioachimescu OC, Sieber S, Kotch A. Idiopathic pulmonary haemosiderosis revisited. Eur Respir J. 2004;24:162–70.

    Article  CAS  PubMed  Google Scholar 

  43. Nuesslein TG, Teig N, Rieger CH. Pulmonary haemosiderosis in infants and children. Paediatr Respir Rev. 2006;7:45–8.

    Article  PubMed  Google Scholar 

  44. Zhang X, Wang L, Lu A, Zhang M. Clinical study of 28 cases of paediatric idiopathic pulmonary haemosiderosis. J Trop Pediatr. 2010;56:386–90.

    Article  PubMed  Google Scholar 

  45. Airaghi L, Ciceri L, Giannini S, Ferrero S, Meroni PL, Tedeschi A. Idiopathic pulmonary hemosiderosis in an adult. Favourable response to azathioprine. Monaldi Arch Chest Dis. 2001;56:211–3.

    CAS  PubMed  Google Scholar 

  46. Kahraman H, Koksal N, Ozkan F. Eight years follow-up of a case with idiopathic pulmonary hemosiderosis after corticosteroid therapy. N Am J Med Sci. 2012;4:49–51.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pathology, Medical University Graz, Graz, Austria

    Helmut Popper

Authors
  1. Helmut Popper
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Popper, H. (2017). Metabolic Lung Diseases. In: Pathology of Lung Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50491-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-50491-8_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-50489-5

  • Online ISBN: 978-3-662-50491-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation